Egerton, Alice
King's College London
16 papers on CoChatORCID 0000-0003-2939-064X
Most cited papers
- Verified
Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies
Merritt, K., Egerton, A., Kempton, M. J., Taylor, M. J., & McGuire, P. K. (2016) · JAMA Psychiatry
Schizophrenia research and treatmentAdvanced MRI Techniques and Applications
Cited by 367
- Verified
Dopamine Synthesis Capacity Before Onset of Psychosis: A Prospective [ 18 F]-DOPA PET Imaging Study
Howes, O. D., Bose, S. K., Turkheimer, F., Valli, I., Egerton, A., Valmaggia, L. R., Murray, R. M., & McGuire, P. (2011) · American Journal of Psychiatry
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 343
- Verified
Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study
Howes, O., Bose, S., Turkheimer, F., Valli, I., Egerton, A., Stahl, D., Valmaggia, L., Allen, P., Murray, R., & McGuire, P. (2011) · Molecular Psychiatry
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 292
- Verified
Presynaptic Striatal Dopamine Dysfunction in People at Ultra-high Risk for Psychosis: Findings in a Second Cohort
Egerton, A., Chaddock, C. A., Winton-Brown, T. T., Bloomfield, M. A. P., Bhattacharyya, S., Allen, P., McGuire, P. K., & Howes, O. D. (2013) · Biological Psychiatry
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 253
- Verified
Midbrain dopamine function in schizophrenia and depression: A post-mortem and positron emission tomographic imaging study
Howes, O. D., Williams, M., Ibrahim, K., Leung, G., Egerton, A., McGuire, P. K., & Turkheimer, F. (2013) · Brain
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 198
- Verified
Striatal dopamine D2/D3 receptor binding in pathological gambling is correlated with mood-related impulsivity
Clark, L., Stokes, P. R., Wu, K., Michalczuk, R., Benecke, A., Watson, B. J., Egerton, A., Piccini, P., Nutt, D. J., Bowden-Jones, H., et al. (2012) · NeuroImage
Gambling Behavior and TreatmentsNeurotransmitter Receptor Influence on Behavior
Cited by 193
- Verified
Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study
Jauhar, S., Veronese, M., Nour, M. M., Rogdaki, M., Hathway, P., Turkheimer, F. E., Stone, J., Egerton, A., McGuire, P., Kapur, S., et al. (2019) · Molecular Psychiatry
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 183
- Verified
Transition to Psychosis Associated With Prefrontal and Subcortical Dysfunction in Ultra High-Risk Individuals
Allen, P., Luigjes, J., Howes, O. D., Egerton, A., Hirao, K., Valli, I., Kambeitz, J., Fusar-Poli, P., Broome, M., & McGuire, P. (2012) · Schizophrenia Bulletin
Schizophrenia research and treatmentPsychopathy, Forensic Psychiatry, Sexual Offending
Cited by 129
- Verified
The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study
Jauhar, S., McCutcheon, R., Borgan, F., Veronese, M., Nour, M., Pepper, F., Rogdaki, M., Stone, J., Egerton, A., Turkheimer, F., et al. (2018) · The Lancet Psychiatry
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 114
- Verified
Adversity in childhood linked to elevated striatal dopamine function in adulthood
Egerton, A., Valmaggia, L. R., Howes, O. D., Day, F., Chaddock, C. A., Allen, P., Winton-Brown, T. T., Bloomfield, M. A. P., Bhattacharyya, S., Chilcott, J., et al. (2016) · Schizophrenia Research
Schizophrenia research and treatmentChild Abuse and Trauma
Cited by 103
- Verified
The effects of antipsychotic treatment on presynaptic dopamine synthesis capacity in first-episode psychosis: a positron emission tomography study
Jauhar, S., Veronese, M., Nour, M. M., Rogdaki, M., Hathway, P., Natesan, S., Turkheimer, F., Stone, J., Egerton, A., McGuire, P., et al. (2019) · Biological Psychiatry
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 75
- Verified
History of cannabis use is not associated with alterations in striatal dopamine D 2 /D 3 receptor availability
Stokes, P. R., Egerton, A., Watson, B., Reid, A., Lappin, J., Howes, O. D., Nutt, D. J., & Lingford-Hughes, A. R. (2012) · Journal of Psychopharmacology
Cannabis and Cannabinoid ResearchNeurotransmitter Receptor Influence on Behavior
Cited by 63
- Verified
Altered activation and connectivity in a hippocampal–basal ganglia–midbrain circuit during salience processing in subjects at ultra high risk for psychosis
Winton-Brown, T., Schmidt, A., Roiser, J. P., Howes, O. D., Egerton, A., Fusar-Poli, P., Bunzeck, N., Grace, A. A., Duzel, E., Kapur, S., et al. (2017) · Translational Psychiatry
Schizophrenia research and treatmentFunctional Brain Connectivity Studies
Cited by 51
- Verified
Dopamine Function in Cigarette Smokers: An [18F]-DOPA PET Study
Bloomfield, M. A., Pepper, F., Egerton, A., Demjaha, A., Tomasi, G., Mouchlianitis, E., Maximen, L., Veronese, M., Turkheimer, F., Selvaraj, S., et al. (2014) · Neuropsychopharmacology
Smoking Behavior and CessationNeurotransmitter Receptor Influence on Behavior
Cited by 48
- Verified
Longitudinal alterations in motivational salience processing in ultra-high-risk subjects for psychosis
Schmidt, A., Antoniades, M., Allen, P., Egerton, A., Chaddock, C. A., Borgwardt, S., Fusar-Poli, P., Roiser, J. P., Howes, O., & McGuire, P. (2017) · Psychological Medicine
Schizophrenia research and treatmentNeural and Behavioral Psychology Studies
Cited by 38
- Verified
Glutamate and Psychosis Risk
Egerton, A., Fusar-Poli, P., & M. Stone, J. (2012) · Current Pharmaceutical Design
Schizophrenia research and treatmentNeuroscience and Neuropharmacology Research
Cited by 36
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free